Transdermal delivery of tadalafil. I. Effect of vehicles on skin permeation

Drug Development and Industrial Pharmacy

Volumn 35, Issue 3, 2009, Pages 329-336

  El Maghraby, Gamal M ^a,b   Alanazi, Fars Kaed ^a   Alsarra, Ibrahim A ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b TANTA UNIVERSITY   (Egypt)

Author keywords

Ethanol ethyl oleate binary systems; Ethanol isopropyl myristate binary systems; Solvents and skin; Tadalafil; Tadalafil transdermal

Indexed keywords

ALCOHOL; DRUG VEHICLE; MACROGOL 400; MYRISTIC ACID ISOPROPYL ESTER; OLEIC ACID ETHYL ESTER; PROPYLENE GLYCOL; TADALAFIL; WATER;

ANIMAL TISSUE; ARTICLE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; DRUG SOLUBILITY; MALE; NONHUMAN; RABBIT; SKIN PENETRATION;

ADMINISTRATION, CUTANEOUS; ANIMALS; CARBOLINES; ETHANOL; MALE; MYRISTATES; OLEIC ACIDS; PHOSPHODIESTERASE INHIBITORS; RABBITS; SKIN ABSORPTION; SOLUBILITY; VEHICLES;

EID: 61649126289     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040802360494     Document Type: Article

References (46)

1. Aungst, B. J., Blake, J. A., & Hussain, M. A. (1990). Contributions of drug solublization, partitioning, barrier disruption, and solvent permeation to the enhancement of skin permeation of various compounds with fatty acids and amines. Pharm. Res., 7, 712-718.
2. Banga, A. K., Bose, S., & Ghosh, T. K. (1999). Iontophoresis and electroporation: Comparisons and contrasts. Int. J. Pharm., 179, 1-19.
3. Barry, B. W. (1983). Dermatological formulation: Percutaneous absorption. New York and Basel: Marcel Dekker.
4. Barry, B. W. (1987). Mode of action of penetration enhancers in human skin. J. Control Rel., 6, 85-97.
5. Bommannan, D., Potts, R. O., & Guy, R. H. (1991). Examination of the effect of ethanol on human stratum corneum in vivo using infrared spectroscopy. J. Control Rel., 16, 299-304.
6. Buvat, J., Van Ahlen, H., Schmitt, H., Chan, H., Kuepfer, C., & Varanese, L. (2006). Efficacy and safety of two dosing regimens of tadalafil and patterns of sexual activity in men with diabetes mellitus and erectile dysfunction: Scheduled use vs. on-demand regimen evaluation (SURE) study in 14 European countries. J. Sex. Med., 3(3), 512-520.
7. Chantasart, D., Li, S. K., He, N., Warner, K. S., Prakongpan, S., & Higuchi, W. (2004). Mechanistic studies of branched-chain alkanols as skin permeation enhancers. J. Pharm. Sci., 93, 762-779.
8. Cheng, C. L., & Chou, C. H. (2005). Determination of tadalafil in small volumes of plasma by high performance liquid chromatography with UV detection. J. Chromatogr. B, 822, 278-284.
9. Corbo, M., Liu, J. C., & Chien, Y. W. (1990). Bioavailability of propranolol following oral and transdermal administration in rabbits. J. Pharm. Sci., 79, 584-587.
10. Costa, P., Buvat, J., Holmes, S., Weitckus, S., Petto, H., Hamidi, K., & Varanese, L. (2006). Predictors of tadalafil efficacy in study comparing two dosing regimen. J. Sex. Med., 3(6), 1050-1058.
11. El Maghraby, G. M. (2008). Transdermal delivery of hydrocortisone from eucalyptus oil microemulsion: Effects of cosurfactants. Int. J. Pharm., 355, 285-292.
12. El Maghraby, G. M., Williams, A. C., & Barry, B. W. (1999). Skin delivery of oestradiol from deformable and traditional liposomes: Mechanistic studies. J. Pharm. Pharmacol., 51, 1123-1134.
13. El Maghraby, G. M., Williams, A. C., & Barry, B. W. (2000). Oestradiol skin delivery from ultradeformable liposomes: Refinement of surfactant concentration. Int. J. Pharm., 196, 63-74.
14. El Maghraby, G. M., Williams, A. C., & Barry, B. W. (2006). Can drug bearing liposomes penetrate intact skin? J. Pharm Pharmacol., 58, 415-429.
15. Golden, G. M., McKie, J. E., & Potts, R. O. (1987). Role of stratum corneum lipid fluidity in transdermal drug flux. J. Pharm. Sci., 76, 25-28.
16. Gorukanti, S. R., Li, L., & Kim, K. H. (1999). Transdermal delivery of antiparkinsonian agent, benzotropine. I. Effect of vehicles on skin permeation. Int. J. Pharm., 192, 159-172.
17. Hedaya, M. A., El-Afify, D. R., & El Maghraby, G. M. (2006). The effect of ciprofloxacin and clarithromycin on sildenafil oral bioavailability in human volunteers. Biopharm. Drug Dispos., 27, 103-110.
18. Higuchi, T. (1960). Physical chemical analysis of percutaneous absorption process from creams and ointments. J. Soc. Cosmet. Chem., 11, 85-97.
19. Holas, T., Vávrová, K., Sima, M., Klimentová, J., & Hrabálek, A. (2006). Synthesis and transdermal permeation-enhancing activity of carbonate and carbamate analogs of transkarbam 12. Bioorg. Med. Chem., 14, 7671-7680.
20. Hrabálek, A., Vávrová, K., Dolezal, P., & Machácek, M. (2005). Esters of 6-aminohexanoic acid as skin permeation enhancers: The effect of branching in the alkanol moiety. J. Pharm. Sci., 94, 1494-1499.
21. Jetter, A., Kinzig-Schippers, M., Walchner-Bonjean, M., Hering, U., Bulitta, J., Schreiner, P., Sorgel, F., & Fuhr, U. (2002). Effects of grapefruit juice on the pharmacokinetics of sildenafil. Clin. Pharmacol. Ther., 71, 21-29.
22. Kikwai, L., Kanikkannan, N., Babu, R. J., & Singh, M. (2002). Effect of vehicles on the transdermal delivery of melatonin across porcine skin in vitro. J. Control Rel., 83, 307-311.
23. Knutson, K., Krill, S. L., & Zhang, J. (1990). Solvent mediated alteration of the stratum corneum. J. Control Rel., 11, 93-103.
24. Kost, J., Pliquett, U., Mitragotri, S., Yamamoto, A., Langer, R., & Weaver, J. (1996). Synergistic effect of electric field and ultrasound on transdermal transport. Pharm. Res., 13, 633-638.
25. Krishnaiah, Y. S. R., Satyanarayana, V., & Karthikeyan, R. S. (2002). Effect of the solvent system on the in vitro permeability of nicardipine hydrochloride through excised rat epidermis. J. Pharm. Pharm. Sci., 5, 124-130.
26. Leichtnam, M. L., Roland, H., Wuthrich, P., & Guy, R. H. (2006). Enhancement of transdermal testosterone delivery by supersaturation. J. Pharm. Sci., 95, 2373-2379.
27. Mezei, M., & Gulasekharam, V. (1980). Liposomes - a selective drug delivery system for topical route of administration. 1. Lotion dosage form. Life Sci., 26, 1473-1477.
28. Miller, L. L., Kolaskie, C. J., Smith, G. A., & Rivier, J. (1990). Transdermal iontophoresis of gonadotropin releasing hormone and two analogues. J. Pharm. Sci., 79, 490-493.
29. Mollgaard, B., & Hoelgaard, A. (1983). Vehicle effect on topical drug delivery. I. Influence of glycol and drug concentration on skin transport. Acta Pharm. Suec., 20, 433-442.
30. Muirhead, G. J., Faulken, S., Harness, J. A., & Taubel, J. (2002). The effect of steady state erythromycin and azithromycin onpharmacokinetics of sildenafil in healthy volunteers. Br. J. Clin. Pharmacol., 53, 37S-43S.
31. Muirhead, G. J., Wulff, M. B., Fielding, A., Kleinermans, D., & Buss, N. (2000). Pharmacokinetic interactions between sildenafil and saquinavir/ritonavir. Br. J. Clin. Pharmacol., 50, 99-107.
32. Panchagnula, R., Desu, H., Jain, A., & Khandavilli, S. (2005). Feasibility studies of dermal delivery of paclitaxil with binary combinations of ethanol and isopropyl myristate: Role of solubility, partitioning and lipid bilayer perturbation. Il Farmaco, 60, 894-899.
33. Panchagnula, R., Salve, P. S., Thomas, N. S., Jain, A. K., & Ramarao, P. (2001). Transdermal delivery of naloxone: Effect of water, propylene glycol, ethanol and their combinations on the permeation through rat skin. Int. J. Pharm., 219, 95-105.
34. Porst, H., Padma-Nathan, H., Giuliano, F., Anglin, G., Varanese, L., & Rosen, R. (2003). Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: A randomized controlled trial. Urology, 62(1), 121-125.
35. Rhee, Y. S., Huh, J. Y., Park, C. W., Nam, T. Y., Yoon, K. R., Chi, S. C., & Park, E. S. (2007). Effects of vehicles and enhancers on transdermal delivery of clebopride. Arch. Pharm. Res., 30, 1155-1161.
36. Ring, B. J., Patterson, B. E., Mitchel, M. I., Gillespie, J., Bedding, A. W., Jewell, H., Payne, C. D., Forgue, S. T., Eckstein, J., Wrighton, S. A., & Phillips, D. L. (2005). Effect of tadalafil on cytochrome P450 3A4-mediated clearance: Studies in vitro and in vivo. Clin. Pharmacol. Ther., 77(1), 63-75.
37. Schreier, H., & Bouwstra, J. (1994). Liposomes and niosomes as topical drug carriers: Dermal and transdermal drug delivery. J. Control Rel., 30, 1-15.
38. Shabsigh, R., Seftel, A. D., Rosen, R. C., Porst, H., Ahuja, S., Deeley, M. C., Garcia, C. S., & Giuliano, F. (2006). Review of time of onset and duration of clinical efficacy of phosphodiesterase type 5 inhibitors in treatment of erectile dysfunction. Urology, 68, 689-696.
39. Sussman, D. O. (2004). Pharmacokinetics, pharmacodynamics and efficacy of phosphodiesterase type 5 inhibitors. J. Am. Osteopath. Assoc., 104(3), S11-S15.
40. Takahashi, K., Tamagawa, S., Katagi, T., Yoshitomi, H., Kamada, A., Rytting, J. H., Nishihata, T., & Mizuno, N. (1991). In vitro transport of sodium diclofenac across rat abdominal skin: Effect of selection of oleaginous component and the addition of alcohols to the vehicle. Chem. Pharm. Bull., 39, 154-158.
41. Thomas, N. S., & Panchagnula, R. (2003). Transdermal delivery of zidovudine: Effect of vehicles on permeation across rat skin and their mechanism of action. Eur. J. Pharm. Sci., 18, 71-79.
42. Touitou, E., Dayan, N., Bergelson, L., Godin, B., & Eliaz, M. (2000). Ethosomes-novel vesicular carriers for enhanced delivery: Characterization and skin penetration properties. J. Control Rel., 65, 403-418.
43. Twist, J. N., & Zatz, J. L. (1988). Membrane-solvent-solute interaction in a model permeation system. J. Pharm. Sci., 77, 536-540.
44. Vávrová, K., Zbytovská, J., & Hrabálek, A. (2005). Amphiphilic transdermal permeation enhancers: Structure-activity relationship. Curr. Med. Chem., 12(19), 2273-2291.
45. Williams, A. C., & Barry, B. W. (2004). Penetration enhancers. Adv. Drug Del. Rev., 56, 603-618.
46. Wilner, K., Laboy, L., & LeBel, M. (2002). The effects of cimetidine and antacid on the pharmacokinetic profile of sildenafil citrate in healthy male volunteers. Br. J. Clin. Pharmacol., 53, 31S-36S.